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Over recent years hyperpolarization by dissolution dynamic nuclear polarization has become an estab-
lished technique for studying metabolism in vivo in animal models. Temporal signal plots obtained from
the injected metabolite and daughter products, e.g. pyruvate and lactate, can be ﬁtted to compartmental
models to estimate kinetic rate constants. Modeling and physiological parameter estimation can be made
more robust by consistent and reproducible injections through automation. An injection system previ-
ously developed by us was limited in the injectable volume to between 0.6 and 2.4 ml and injection
was delayed due to a required syringe ﬁlling step. An improved MR-compatible injector system has been
developed that measures the pH of injected substrate, uses ﬂow control to reduce dead volume within the
injection cannula and can be operated over a larger volume range. The delay time to injection has been
minimized by removing the syringe ﬁlling step by use of a peristaltic pump. For 100 ll to 10.000 ml, the
volume range typically used for mice to rabbits, the average delivered volume was 97.8% of the demand
volume. The standard deviation of delivered volumes was 7 ll for 100 ll and 20 ll for 10.000 ml demand
volumes (mean S.D. was 9 ul in this range). In three repeat injections through a ﬁxed 0.96 mm O.D. tube
the coefﬁcient of variation for the area under the curve was 2%. For in vivo injections of hyperpolarized
pyruvate in tumor-bearing rats, signal was ﬁrst detected in the input femoral vein cannula at 3–4 s
post-injection trigger signal and at 9–12 s in tumor tissue. The pH of the injected pyruvate was
7.1 ± 0.3 (mean ± S.D., n = 10). For small injection volumes, e.g. less than 100 ll, the internal diameter
of the tubing contained within the peristaltic pump could be reduced to improve accuracy. Larger injec-
tion volumes are limited only by the size of the receiving vessel connected to the pump.
 2013 The Authors. Published by Elsevier Inc. Open access under CC BY license.1. Introduction
Dissolution dynamic nuclear polarization (dDNP) [1] has affor-
ded a step change in the available MR signal for nuclei such as
13C. It has most extensively been applied to hyperpolarized MR
imaging and spectroscopy used for the assessment of in vivo
metabolism, with considerable interest in elucidating the glyco-
lytic pathway, e.g. intravenously injected hyperpolarized 13C-pyru-
vate conversion to lactate. In contrast to conventional (thermally
polarized) MR, the hyperpolarized signal is transitory due to T1relaxation. This means that the dDNP experiment must be con-
ducted as rapidly as possible, within a few multiples of the T1
relaxation time, before the signal decay becomes too signiﬁcant.
The hyperpolarized signals are acquired rapidly to provide spectro-
scopic information on the conversion of the injected substrate to
its metabolites within the tissue of interest and has been applied
to the imaging of tumors [2] and their response to drug treatment
[3]. Further development of the methodology has allowed the tem-
poral signal plots obtained from tissue to be ﬁtted to compartmen-
tal models to estimate kinetic rate constants [4]. We have shown
previously that a reproducible injection/withdrawal system can
be used to provide a consistent arterial input function for compart-
mental modelling and extraction of physiological parameters [5]. A
rapid and reproducible injection regime is also highly desirable for
comparative hyperpolarization studies, where a precisely delivered
dose to each subject is of prime importance.
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vided reproducible injection volumes, rates and timing for animal
studies [5]. However, because of its syringe-based design, it was
limited in the range of volumes it could deliver: 0.6–2.4 ml – a vol-
ume range typically used for the injection of rats. Also, the injec-
tion was delayed by a few seconds because of the syringe ﬁlling
stage required by this system.
As the hyperpolarized signal lifetime is governed by T1 relaxa-
tion, reducing the delay between dissolution and injection can im-
prove the magnitude of the signal, particularly for short T1
molecules. Moreover, extending the working range of the inject-
able volume would allow the application of the injection system
to a wider range of species. Other design features for the injection
system should ensure homogeneous composition of the ﬁnal
hyperpolarized substrate, coupled with ﬂow control to minimize
the dead volume of the injection received by the animal, monitor-
ing of pH and ease of use. Here we show an improved MR compat-
ible automated injector system that fulﬁls these requirements.
2. Materials and methods
2.1. Injector design
The injector consists of a peristaltic pump directly driven
through a ﬂexible drive shaft by a stepper motor. A high torque
bipolar stepper motor (57BYG621, Wantai Motor, Changzhou, Chi-
na) was mounted on to a housing ﬁxed to the magnet room ﬁlter
plate outside the 5 G line of the magnet, see Fig. 1. The non-mag-
netic ﬂexible drive shaft was constructed of a 4 mm phosphor-Fig. 1. (a) Overview of injector system design showing the control system with the step
drive shaft and 3-way stopcock, and (c) image of injector system.bronze shaft, 2.5 m in length (SS White Technologies Ltd., Milton
Keynes, UK), inserted into a 6 mm O.D. nylon tube. The drive shaft
was interfaced with a plastic peristaltic pump (150 series, William-
son Pumps Ltd., Poynings, UK) mounted on its own plastic ma-
chined polyoxymethylene (POM) chassis. The pump and chassis
were bolted to a rubber plate to minimize vibration from the step-
per motor and a POM/Perspex support stand was used to form the
complete injection system. An adjustable screw was ﬁtted to the
rear of the peristaltic pump to vary the degree of compression ex-
erted by the pump housing on the tubing contained within the
peristaltic pump. This was done in order to reduce the torque
requirement for the drive shaft and stepper motor. The injection
system incorporates a receiving vessel, attached to the inlet port
of the pump, for collection and neutralization of the substrate to
be injected, when this is required. The output of the pump was
connected to a 3-way Luer lock stopcock (Becton Dickson) to per-
mit easy connection to an intravenous cannula and, after switching
the ﬂow direction, for ﬂushing pipework. Control of the stepper
motor and injection system was realized by an Arduino microcon-
troller, as described below.
2.2. Receiving vessel design
Homogeneity and pH of the injected substrate is important for
in vivo applications. For manual injection of substrate, the operator
can agitate the liquid to improve its homogeneity. This is a partic-
ular requirement for pyruvic acid which, prior to injection, must be
converted to its salt by reacting with a pre-determined aliquot of
sodium hydroxide. For an automated system, the design of the de-per motor, ﬂexible drive shaft and pump and the receive vessel, (b) pump chassis,
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injection. A custom receive vessel (RV) was designed to ensure
smooth ﬂow of liquid into the vessel in order to minimize acid or
base splashing on the walls. The RV was constructed from a
120 mm polycarbonate egg shape (Polycraft supplies, Cardiff, UK)
machined to permit inlet of services, see Fig. 2. After dissolution,
hyperpolarized substrate ﬂows into the RV from the DNP polarizer
through a 3 mm O.D. ﬂuorinated ethylene propylene (FEP) pipe
that passes into a 6 mm I.D. Tygon guide pipe (Cole-Parmer, Lon-
don, UK) glued inside the RV vessel wall. The guide pipe allowed
consistent positioning of the dissolution pipe half way up the ves-
sel wall. At the end of the FEP pipe was a nozzle to guide the liquid
down the RV wall. Hyperpolarized substrate was withdrawn from
the RV into the pump via a side port ﬁtted into the lower section of
the RV.
In this implementation, a predetermined aliquot of 2.0 M so-
dium hydroxide was added to the RV prior to ingress of the pyruvic
acid. To ensure thorough mixing of pyruvic acid with the sodium
hydroxide, an air driven stirrer was inserted into the RV, see
Fig. 2. The stirrer was constructed with a POM paddle wheel on a
2 mm diameter ﬁber glass spindle, 14 cm in length. At the other
end of the spindle there were 4 cm horse hair brush ﬁbers which
were submerged in the liquid to rapidly stir and homogenize the
mixture. The paddle wheel was located inside a housing and driven
by an air supply automatically gated on using a pneumatic control
valve and the Arduino microcontroller. Also, inside the RV there
were placed a few (5–7) 2 mm diameter glass beads that helped
to damp liquid motion when pyruvic acid ﬁrst entered.
The pH of the injected substrate was automatically measured
during the dissolution procedure using a pH electrode (ASP200-
2-1M-BNC, Active robots Ltd., Radstock, UK) placed in the RV.
The pH electrode was connected to a custom built ampliﬁer that
had a variable output voltage in response to changes in pH, see
Supplementary information. The ampliﬁer was connected to an
analogue to digital converter input on the microcontroller. By
titrating 45 mg pyruvic acid against 2.0 M sodium hydroxide overFig. 2. Schematic and image of hyperpolarized ﬂuid receive vessel (not to scale). Shown a
was inserted), air driven stirrer, pH electrode and vacuum pipe. Connection to an animaa pH range of 1.8-–13.0, voltage versus pH was plotted and used
to generate a linear calibration equation. The pH electrode could
also be calibrated from within the Arduino software by measuring
the electrode voltage in 3 different buffer solutions (pH 4, pH 7, pH
10) and calculating a linear equation for pH versus voltage.
Also connected into the RV was a 6 mmO.D. pipe connected to a
vacuum pump (GAST GF3, Gast Manufacturing Inc., MI) to reduce
back pressure during transfer of hyperpolarized solution. The vac-
uum pump was gated on/off by the HyperSense DNP polarizer.
2.3. Flow diverter system design
Injection volumes for each species are limited to ensure that the
circulation of the animals is not overloaded. The physical con-
straints of an MRI scanner require a long length of cannula line
for i.v. injections, resulting in a signiﬁcant dead volume that con-
tributes to the injection volume. This is problematic where hyper-
polarized signal is limited. If, for example, saline occupies the dead
volume of the cannula then, during injection, its volume must be
considered part of the dose and yet it does not contribute to the
measured hyperpolarized signal. To increase the percentage the
hyperpolarized compound contributes to the injected volume,
the dead volume was reduced by splitting the cannula into two
pathways without introducing additional dead volume; one path-
way was then used as a waste stream for clearing the dead space
volume whilst the other was used for drug administration into
the animal. Flow direction was computer-controlled by valves.
A ﬂuid diverter cannula was constructed using two types of tub-
ing: 0.96 mm O.D. polyethylene tube (Portex, Smiths Medical, St.
Paul, MN), hereby referred to as ‘small tube’ and 1.0 mm I.D. Tygon
tube (Cole-Parmer, London, UK), hereby referred to as ‘large tube’.
Tygon tubing was used as its mechanical properties permit multi-
ple compressions without permanent damage. A 19 gauge Luer
hub was drilled to enlarge its inner diameter to 2 mm, see Fig. 3,
into which the ends of three 30 mm lengths of small tubing were
inserted to ensure the hole was almost completely occupied; onere the receive vessel with pipe guide (into which the DNP polarizer dissolution pipe
l cannula is made via a Luer 3-way stopcock ﬁtted to the outlet of the pump.
Fig. 3. Flow diverter conﬁguration showing: (a) schematic of ﬂow diverter cannula,
pinch valve for controlling ﬂow to the rat and normally closed (NC) diaphragm
valve, (b) complete ﬂuid path for ﬂow diversion system, and (c) 2 pinch valves.
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which was inserted into a rat vein, whilst the third one was unused
and blanked off. The tubes were then sealed to the Luer hub with
glue. Onto the waste pathway 200 mm of large tubing was glued
and terminated with a Luer 3-way stopcock to prevent animal
bleeding during surgery. The animal pathway was continued with
a short 30 mm piece of large tubing followed by a 180 mm length
of small tube that would be used to cannulate the animal. To allow
access from outside the magnet, an 800 mm length of small tub-
ing was attached upstream of the two-way cannula with a 21
gauge luer hub glued at one end and with the other end potted into
a male–male Luer adapter (Cole-Parmer) using dental cement, see
Fig. 3.
Fluid ﬂow pathway was guided using a custom-made pinch
valve and a normally closed diaphragm valve (PMDP-2R-M6G,
Takasago, Nagoya, Japan), both actuated by pneumatic pressure
and controlled by an Arduino microcontroller. A custom made
pinch valve chassis was machined from polycarbonate (PC) with
a 10 mm syringe/plunger that actuated a PC cylinder that acted
on the Tygon tube, see Fig. 3. When air pressure was applied either
one or both valves could be opened or closed. Air pressure was sup-
plied by a custom made pneumatic control box with independent
control valves that could be turned on by a 5 V input provided by
the Arduino microcontroller.
Once the diverter cannula had been surgically inserted into the
animal and the animal transferred to the magnet, the animal path-
way line was inserted into the pinch valve (at the Tygon position)
and held in place by a plastic gate. The waste line of the ﬂuid path
was connected to the diaphragm valve and the 3-way stopcock
opened to provide a continuous ﬂuid outlet path to waste outside
of the magnet.On injection, the Arduino microcontroller was programed to
open the waste line valve and close the rat line valve and pump.
Typically 0.6–0.8 ml of liquid went to waste. The ﬂuid path was
then switched to the rat by opening the rat line valve and closing
the waste line and the desired injection volume was delivered to
the rat. During idle mode, the rat side valve was left open to pre-
vent damage to the Tygon tube.
2.4. Injector control system
The injector pump system was controlled through a computer
serial link to an Arduino Uno R3 microcontroller (Arduino.cc).
The microcontroller controlled the stepper motor via custom made
stepper motor driver electronics. The ﬂow diverter and air stirrer
were operated via a custom made pneumatic control box which
provided air pressure (pre-set at 40–60 PSI) in response to 5 V in-
put signals. Trigger of the injection sequence was started in re-
sponse to a 5 V signal (greater than 10 ms duration to eliminate
false triggering) from either the HyperSense polarizer or scanner
console to the microcontroller. Once the injection system had been
placed in trigger standby, the pH in the RV was reported every 30 s
for up to 2 min 10 s (a duration chosen to be 20 s shorter than the
polarizer’s dissolution solvent heating preparation time). After
2 min 10 s the pH was reported every 1 s in order to record the
neutralization of pyruvic acid by sodium hydroxide, see below.
On receiving a trigger signal a ﬁnal pH was reported. A software
option was available to gate whether the injection proceeded if
the pH was within a predeﬁned range, e.g. pH 7 ± 1. The reported
pH was estimated to be accurate to ±0.1.
Other devices requiring external device control could be con-
nected to the available external digital output pins of the Arduino
board.
User-programed software functions controlled the activity of
the pump, permitting multistep ﬂow rates, volumes (absolute or
calculated volume as a function of animal weight for a given dose)
and ﬂow direction. Volume calculations were made by the soft-
ware using a calibration volume based on a single revolution by
the stepper motor. Using a software function, the calibration vol-
ume could be determined based on the mass of water delivered
after ten revolutions of the stepper motor or by adaptive volume
calibration, in which the calibration volume was internally ad-
justed based on the measured volumes and compared against the
requested volume by the software. Additional features included a
cleaning routine using ﬂow control to ﬂush the pump and cannula
whilst still connected to the animal.
2.5. Volume delivery calibration and test
The pump was ﬁrst calibrated by three measurements of the
mass of distilled water delivered through 1100 mm of 0.96 mm
O.D., 0.58 mm I.D. tube into a glass vial after ten revolutions of
the pump at 80 rpm. The average water mass divided by ten was
then entered into the software as a volume per revolution. All sub-
sequent volumes were calculated by the software based on this
calibration. The accuracy and scalability of the injection system
delivered volumes were measured against programed volumes in
the range 0.100–10.000 ml for an arbitrarily chosen constant ﬂow
rate of 7.0 ml/min. The delivered volume for a given demanded
volume was similarly measured at least three times (range 3–5)
by mass of distilled water.
2.6. Hyperpolarized 13C1 pyruvic acid experiments
The delivery of hyperpolarized substrate was tested ﬁrstly
in vitro and subsequently in vivo. In both types of experiments
13C1 pyruvic acid (PA) (Sigma Aldrich, Gillingham Ltd., UK) was
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don, UK) and 1.5 mM DOTAREM (Guerbet, Roissy, France). 45 mg
(12.7 mg for in vitro tests) of PA was hyperpolarized using a Hyper-
Sense DNP polarizer, operating between 1.2 and 1.4 K, using a
microwave frequency 94.150 GHz and 30 mW for approximately
1 h. The hyperpolarized frozen sample was transferred to the re-
ceive vessel using 3.4 ml superheated buffer solution containing
40 mM HEPES buffer solution, 0.269 mM disodium EDTA and
50 mM NaCl (all obtained from Sigma Aldrich). The receive vessel
contained a predetermined aliquot of 2.0 M sodium hydroxide
solution (Sigma Aldrich) required to neutralize the PA and 2.0 ml
HEPES/EDTA buffer solution to ensure that the receive vessel outlet
pipe was submerged. Final concentration of PA was 100 mM. The
transfer time of the hyperpolarized solution from the polarizer was
6 s, after which a trigger signal was sent to the Bruker 7T small ani-
mal scanner (310 mm horizontal bore, with 400 mT/m, 120 mm
I.D. gradient insert, Bruker Biospin MRI GmbH, Ettlingen, Germany)
to commence acquisition and start the injection procedure.2.7. In vitro experiments
Two separate experiments were performed to test the delivery
and reproducibility of the injection system. First, for volume deliv-
ery, an injection was performed using hyperpolarized 13C pyruvate
into a plastic vial mounted on a 20 mm 13C/1H surface coil (Bruker)
placed at the center of the magnet. Second, a 0.96 mm O.D. cannula
tube was attached to the injector and positioned so that it ran in a
straight horizontal direction across the face of the surface coil, par-
allel to the z-axis at a distance of 5 mm from the coil surface. ThisFig. 4. (a) Sketch of rat showing location of surface coil and routing of i.v. cannula, (b) axia
representation (blue box) of the surface coil location and guide lines for 2 slices are also sh
referred to the web version of this article.)conﬁguration was undisturbed for three consecutive injections. In
both experiments the injection was programed to deliver 1.50 ml
of pyruvate at 6.92 ml/min, simultaneously starting with the MR
acquisition sequence. A 6.7 M acetate phantom was attached on
the other side of the coil to provide a reference signal. The 13C sig-
nal was localized using a 20, 0.5 ms Gaussian pulse and 10 mm
slice selection. 180 consecutive spectra (sw = 50 ppm, 256 points)
were acquired with a TR = 1 s; 180 s total duration. Integrals were
measured from spectra using custom Matlab software (Maths-
Works Inc., Natick, MA).2.8. In vivo experiments
Animal experiments were conducted in accordance with the
United Kingdom Animals (Scientiﬁc Procedures) Act 1986, with lo-
cal ethical approval and following published guidelines for the use
of animals in cancer research [7].
BDIX rats, with subcutaneously implanted P22 tumors, were
anaesthetized with 1.5–2% isoﬂurane at 2 L/min via a nose cone
and the tail vein was cannulated for 13C1-pyruvate (PA) delivery.
The rat was placed in a Bruker 7T MRI system with its temperature
maintained by an electric heating pad and rectal temperature
probe. Respiration rate was also monitored. A 20 mm 13C/1H sur-
face coil was placed 1–2 mm above the tumor, with the I.V. tail
vein diverter cannula routed over the top of the surface coil to pro-
vide an in vitro reference signal, see Fig. 4a. 13C signals were local-
ized in the tumor by 8 mm coronal slice selection with a 20 0.5 ms
Gaussian pulse. All other acquisition parameters were the same as
the in vitro experiment. 5 ml/kg of hyperpolarized PA at 100 mMl FLASH image of the tumor, reference phantom and femoral vein cannula. A cartoon
own. (For interpretation of the references to color in this ﬁgure legend, the reader is
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diverter. From the resulting spectra 13C pyruvate peak integrals
versus time response curves were processed using Matlab.
To locate the slice positions for the hyperpolarized PA experi-
ments, structural images of the tumor were acquired with the
20 mm 13C/1H surface coil using a FLASH sequence (FOV
60  60 mm, 256  256 matrix, 13 slices, 1 mm thickness, TR/TE
164.71/6 ms). A representative image is shown in Fig. 4b.
3. Results
3.1. Volume delivery correlation with demand volume
The reproducibility of the injection volume was tested by mea-
suring the mass of water delivered. Delivery times for 100 ll to
10.00 ml volumes at a constant ﬂow rate of 7 ml/min ranged from
0.9 to 86 s. Delivered volumes versus the demand volumes were
plotted in Fig. 5. An excellent linear correlation was found between
the demand and delivered volumes, from 100 ll to 10.00 ml with
r2 = 1. Across the entire measured range, the mean delivered vol-
ume was found to be 97.8% of the demanded volume. The standard
deviation of delivered volumes was 7 ll for 100 ll and 20 ll for
10.000 ml demand volumes (mean S.D. was 9 ll in this range).
3.2. Hyperpolarized experiments
3.2.1. In vitro test
By acquiring the 13C MR signal, the delivery proﬁle of 1.5 ml of
hyperpolarized pyruvate at 6.92 ml/min (13 s pumping time) was
measured as it was injected into a plastic vial, see Fig. 6a. 13C spec-
tra acquisition started simultaneously with the pump after a trig-
ger signal from the HyperSense. The ﬁrst detected signal in the
vial appeared at 6 s after the injection started, with the maximum
signal observed at 13 s – coinciding with the end of the injection
time point. For three repeat injections through a ﬁxed tube, the
overlaid absolute integral plots closely matched each other, see
Fig. 6b. From measurements of the area of each curve the coefﬁ-
cient of variation was 2%.
3.3. In vivo DNP/MR experiments
After the pump system had been tested in vitro it was then em-
ployed for in vivo injections over 13 s into P22 sarcoma bearing
BDIX rats using the ﬂow diverter system. With the surface coil
positioned over the tumor, 13C spectra were simultaneously ac-
quired both from the tumor and from the tail vein cannula located
above the surface coil. Fig. 7a shows that the 13C signal from theFig. 5. Demand volume versus average delivered volume for at least 3 measure-
ments by mass of water. Error bars represent the standard deviation in delivered
volume. Inset shows zoomed region of main ﬁgure in the volume range 0.00–
2.00 ml.tail vein cannula signal ﬁrst appeared at 3–4 s after the trigger sig-
nal started the signal acquisition and injection sequence, reﬂecting
the time of ﬂight of hyperpolarized substrate through the pump
and cannula to the rf coil. The tumor pyruvate signal ﬁrst appeared
at 9–12 s after the trigger signal and reached maximum at 21–23 s.
There was approximately 13 s between appearance and maximum
signal in the observed tumor, closely matching the period of injec-
tion. The pH (measured post-injection using IQ150 pH meter, Hach
Company, Loveland, CO) of the injected pyruvate was 7.1 ± 0.3
(mean ± S.D.) for 10 animals.4. Discussion
The design of the injection system permitted reproducible
administration of hyperpolarized substrate with minimal human
intervention. The plastic/non-ferrous construction of the injector
allows it to be positioned next to the bore of the magnet (tested
at fringe magnetic ﬁeld strengths of 1 T). In this implementation
the drive shaft length was chosen so that the drive motor was out-
side the 5 G line. The drive shaft could be shortened or lengthened
in accordance with magnet room layout, although care must be ta-
ken over choice of the diameter of longer drive shafts to prevent
excessive twisting. An excellent correlation between demandedFig. 6. In vitro delivery proﬁle for injection of 1.50 ml of hyperpolarized pyruvate
over 13 s as measured by the integral of the 13C PA signal. Temporal data acquisition
commences simultaneously with injector start. 6.7 M 13C sodium acetate used as
signal reference; (a) single injection into vial mounted on a 20 mm 13C/1H surface
coil, (b) 3 repeat injections through a ﬁxed horizontal tube located 5 mm from 13C
surface coil surface (color matched solid lines pyruvate signal, dotted colored lines
acetate reference. Vertical dashed line at 13 s). (For interpretation of the references
to color in this ﬁgure legend, the reader is referred to the web version of this
article.)
Fig. 7. Normalized integral for hyperpolarized 13C pyruvate versus time for 5 ml/kg
injection over 13 s in three rats, (a) 13C signal from tail vein cannula and (b) slice
localized 13C signal from tumor (dotted lines – lactate signal). In both ﬁgures the
traces are color matched for individual animals. (For interpretation of the references
to color in this ﬁgure legend, the reader is referred to the web version of this
article.)
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0.100 to 10.00 ml, a volume range that is typically used for mice
and larger animals such as rabbits. Delivered volume was also
highly reproducible over this large volume range. Should smaller
volumes, e.g. less than 100 ll, be required then the internal diam-
eter of the tubing contained within the peristaltic pump could be
reduced to improve accuracy.
Over the past few years a number of different solutions have
been designed to address reproducibility in delivery of hyperpo-
larized substrate. A system by Bowen and Hilty [8] was designed
for in vitro use to rapidly (1200 ms) inject hyperpolarized disso-
lute into a high resolution NMR spectrometer. Speciﬁcally their
system used high pressure, >40 bar, to ensure that an aqueous
solution reliably ﬁlled a 5 mm NMR tube without air bubbles –
a common issue due to the high viscosity and surface tension of
water. Due to its high operating pressure their design would not
be readily applicable to in vivo use without stepping down the
pressure.
A computer controlled in vivo injector was described by Com-
ment et al [9], further improved in [10], that addressed the issue
of bubble formation by allowing the chase gas (used to assist trans-
fer of the sample from the polarizer to the injector) to exit through
vents. A hydraulically driven plunger then sealed the vent holes as
the sample was injected into the animal. An in-line optical sensor
halted the injection if a bubble was detected within the injection
cannula. The presence of a vent hole affects the accuracy of such
a system, as there would be some variability in the amount of li-
quid injected into the animal as these vents were sealed. Hydraulicbased systems also have some inaccuracy due to friction in actuat-
ing the hydraulic cylinder(s). In our described system, the possibil-
ity of injecting an air bubble was minimized by having a
continuous ﬂuid path from the cannula to the RV. The outlet pipe
of the RV to the pump was also always submerged. The ingress
of hyperpolarized substrate passed down the side of the RV wall
to smoothly ﬁll the RV and a vacuum pump removed excess gas.
In practice, no bubbles were found to have formed within the RV
and so this was not regarded as a safety issue. However, an optical
bubble detection system, as described [9], could be added and
operated with the ﬂow diversion system described here to prevent
accidental injection of air into the animal. The design of the RV
would permit other quality control systems, similar to those used
in a clinical DNP polarizer [11], e.g. volume, temperature, free rad-
ical concentration sensors, to be added. Although not included on
the current injector, an electrical or chemical heating system
would prevent administration of relatively cold substrate to the
animal. This would be due to the reduced temperature of the
hyperpolarized substrate as it passes through the cannula to the
animal while in the room temperature magnet bore (14 C). Injec-
tion of cool substrate has been observed by us to cause an approx-
imate 0.5 C temperature drop in the animal, as measured by a
rectal temperature probe (data not shown), although it is not yet
known whether this inﬂuences substrate delivery to subcutaneous
tumors or pyruvate kinetics. Inclusion of a pH electrode allows on-
line monitoring of the hyperpolarized substrate during the dissolu-
tion process to provide additional animal safety. A glass pH
electrode can take up to 30 s to attain a stable value, although an
approximate value can be measured within a few seconds. Because
of this, using the built in pH monitor introduced a few seconds de-
lay to the injection and so was not always used.
The delay between dissolution and injection has been mini-
mized by using a peristaltic pump to remove the syringe ﬁlling de-
lay required for a previous automated injector design [6]. The
reduction of dead time from dissolution to start of the injection
is a key factor in the 13C MR studies of hyperpolarized substrates.
Saving 1–5 s, depending on the required syringe ﬁlling volume,
can be an important improvement in terms of experimental sensi-
tivity. Moreover, automation of a combined polarizer and injection
system, as seen in the in vitro results, can produce a very high de-
gree of consistency in the level of the hyperpolarized signal by ﬁx-
ing the timing and dose of the substrate. The T1 of hyperpolarized
pyruvate has been shown to be highly dependent on magnetic ﬁeld
strength [12] thus affecting the observed level of signal. The injec-
tion system can be reproducibly positioned next to the magnet
such that the sample experiences a well-deﬁned magnetic ﬁeld
path during transfer from the polarizer. In principle the observed
in vivo signal can be corrected for timing differences using T1. How-
ever, in vivo values of T1 have been published in the range 18–31 s
[13,14], making this method potentially inaccurate. Provided that
the injection cannula was consistently positioned with respect to
the surface coil, the level of hyperpolarized signal between injec-
tions could be measured to assess reproducibility. Combining this
measurement with a reference phantom signal would allow the
polarization to be calculated. Measuring the hyperpolarized signal
in the cannula would cause a reduction of the signal acquired from
the animal. However, this measurement could be delayed until
after the substrate had been fully administered.
When the injection system was used in vivo, the 13C MR signal
could be ﬁrst detected within the tissue of interest 8–12 s after
transfer of hyperpolarized pyruvate from the polarizer, minimizing
hyperpolarization loss and therefore improving the available sig-
nal. Variations in the appearance time of the 13C signal in the tu-
mor are most likely caused by differing blood circulation times
and tumor vascularity between animals.
8 S. Reynolds et al. / Journal of Magnetic Resonance 239 (2014) 1–8By using a fully programmable microcontroller, the operation of
the injector can be customized to the user’s needs. The consistency
of injection ﬂow rate and timing by computer-control ensures a
reproducible dose to the animal, allowing hyperpolarized signal
to be more readily compared across experiments. While keeping
important attributes of the previously developed injector, e.g.
reproducible injection volume and ﬂow rate through automation,
the new system provides an improvement in the speed, reproduc-
ibility, accuracy and scalability of the volume that can be delivered.
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